548 Folgen

  1. Treating Huntington's Disease by Addressing Neuroinflammation

    Vom: 24.6.2020
  2. How Patient Advocate-Led Research Can Alter a Rare Disease Landscape

    Vom: 17.6.2020
  3. Keeping Clinical Trials Going During a Pandemic

    Vom: 10.6.2020
  4. Looking for Commonalities in Rare

    Vom: 3.6.2020
  5. Learning to Be Comfortable Being Uncomfortable

    Vom: 27.5.2020
  6. An Approach to De-Risk Rare Disease Drug Development

    Vom: 20.5.2020
  7. Targeting Epigenetics in Rare Proliferative Bone Marrow Cancers

    Vom: 13.5.2020
  8. Chiesi Charges Ahead in Rare Disease

    Vom: 6.5.2020
  9. Targeting the Metabolism of Rare Cancers

    Vom: 29.4.2020
  10. Unlocking Bryson's Brain

    Vom: 22.4.2020
  11. Living Therapies for Chronic Conditions

    Vom: 15.4.2020
  12. A One-to-Many Approach to Gene Therapy for Retinal Disease

    Vom: 8.4.2020
  13. Targeting an Immune Switch in Rare Diseases

    Vom: 1.4.2020
  14. Targeting the Regulatory Genome to Treat Rare Blood Diseases

    Vom: 25.3.2020
  15. A Reborn Forma Therapeutics Focuses on Rare Blood Diseases and Cancer

    Vom: 18.3.2020
  16. Targeting Genetic Diseases at Their Root Cause

    Vom: 11.3.2020
  17. Targeting Hormone Dysregulation in Prader-Willi Syndrome

    Vom: 4.3.2020
  18. Rare Disease Advocates Take to the Hill

    Vom: 25.2.2020
  19. Targeting a Common Link in Otherwise Different Rare Diseases

    Vom: 19.2.2020
  20. Bringing Clinical Trials to Patients

    Vom: 12.2.2020

14 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site